The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Bringing Consistency to Gout Terms & Concepts

Bringing Consistency to Gout Terms & Concepts

November 2, 2020 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF

gout magnifying glass imageThe umbrella term crystalline disease covers arthritic conditions caused by deposition of crystals and associated inflammatory response, including erythema, edema and intense pain. The two most common crystal-induced arthropathies are gout, an arthritis secondary to inflammation caused by the presence of monosodium urate (MSU) crystals formed through high levels of serum urate, and calcium pyrophosphate deposition disease (sometimes called pseudogout). Gout also describes the clinical symptoms and signs associated with the body’s potent inflammatory response to MSU crystal deposition.

You Might Also Like
  • Potential Link Between OA & Gout
  • Dual-Energy CT May Help Detect Gout Patients at Risk for Heart Disease
  • Contemporary Prevalence of Gout & Hyperuricemia in the U.S.

The lack of standardized terminology or consistent definitions for gout and other crystalline diseases results in technically inaccurate uses of the terms, with implications for how disease-related concepts are communicated in clinical and research settings, says David Bursill, MD, a rheumatologist in the Department of Health and Medicine Sciences, University of Adelaide, South Australia.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Different terms are used interchangeably to describe different disease states. While there is no universally accepted definition of gout itself, more accurate nomenclature could facilitate better understanding of the disease and related concepts,” he explained in an email exchange with The Rheumatologist. Dr. Bursill is lead author and nomenclature research fellow for a consensus statement on labels and definitions for gout and other crystalline disease states.1 The statement is the work of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN; g-can.org), a multidisciplinary, international, nonprofit organization based in Seattle.

Dr. Bursill attributes the historical lack of standardized terminology for gout to the fact that this condition has been described since ancient times, with long-ingrained usages. “The various terms have accumulated over history without any effort to refine the nomenclature. We have found the currently used terms, apart from lacking standardization, often are technically inaccurate—such as using serum uric acid instead of the correct term, serum urate—or else convey a misleading message to care providers and patients,” he says. For example, the terms chronic gout and acute gout misleadingly imply the condition exists in two separate forms. There has also been little attention to related preclinical states.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Defining Disease States

G-CAN members conducted a content analysis of 539 articles on gout and hyperuricemia in the rheumatology and internal medicine literature, published between January 2013 and January 2018. According to this analysis, disease states—defined as “clinically meaningful clusters of the presence, or absence, of two or more disease elements”—were infrequently mentioned, poorly defined or inconsistently labeled. Sixty-three unique labels exist for 13 identified disease states in gout.

To develop the consensus statement, three rounds of Delphi exercises were conducted via email with 76 G-CAN members from Europe, North America, the Asia-Pacific region and Latin America to ascertain which disease states were meaningful to participants and how to define them. A subsequent face-to-face meeting of 35 of the respondents was convened Oct. 20, 2018, in Chicago to reach agreement on eight recommended disease state labels:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  • Asymptomatic hyperuricemia, in the absence of gout;
  • Asymptomatic MSU crystal deposition, which may be demonstrated by imaging or microscopic analysis;
  • Asymptomatic hyperuricemia with MSU crystal deposition;
  • Gout;
  • Tophaceous gout, with at least one subcutaneous tophus;
  • Erosive gout, with at least one gouty bone erosion;
  • First gout flare; and
  • Recurrent gout flares.

Basic Elements of Gout

Pages: 1 2 | Single Page

Filed Under: Conditions, Crystal Arthritis, Guidelines Tagged With: Gout, Gout Resource Center

You Might Also Like:
  • Potential Link Between OA & Gout
  • Dual-Energy CT May Help Detect Gout Patients at Risk for Heart Disease
  • Contemporary Prevalence of Gout & Hyperuricemia in the U.S.
  • New Gout Criteria from the ACR/EULAR Focus on Clinical Trials, Global Standards

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.